Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Turtle (TURTLE) Price & Performance

InjectiveTrade
TurtleTrade

Price performance (Past 24H)

Key statistics

Injective vs Turtle — how do they compare? Injective trades at Rp92,221 (market cap Rp9,27T, Rp1,77T 24h volume), while Turtle trades at Rp610.52 (market cap Rp94,68M, Rp33,31M 24h volume). The key difference: Injective is far larger — about 97908.7× Turtle's market cap, and Turtle's supply is capped (154,7M / 1B TURTLE (16%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Turtle for 11 Days on average.

INJTURTLE
Market Cap
Rp9,27TRp94,68M
Volume (24h)
Rp1,77TRp33,31M
Circulating Supply
100M INJ154,7M / 1B TURTLE (16%)
Typical Hold Time
36 Days11 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp90,066 with a market cap of Rp8.94 trillion, exhibiting a bullish technical signal supported by moving averages while oscillators remain neutral. The current price sits above key support levels, with resistance near Rp93,589. Recent on-chain data indicates an average hold time of 36 days, suggesting moderate holder confidence. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.

Overall outlook is cautiously optimistic due to bullish technicals, but key risks include high volatility and neutral oscillators signaling potential overbought conditions. Opportunities lie in continued network adoption, while investors should monitor regulatory developments and liquidity depth closely. Major risks involve crypto market volatility and lack of recent fundamental catalysts.

Turtle

TURTLE is trading at Rp612.17 with a bearish technical signal, showing weak momentum as it hovers near the pivot point of Rp610. The asset has a low circulating supply of 16% (154,700 tokens out of 1 million max), and an average hold time of 11 days indicates short-term trading interest. No major protocol updates or ecosystem developments were noted in recent data.

Overall outlook is cautious due to bearish technicals and limited network activity. Key opportunities include potential rebounds from support levels like Rp589, but risks involve low liquidity, high volatility, and minimal adoption. Investors should monitor for any token utility enhancements or exchange listings to gauge future viability.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
TURTLE
98% Buy2% Sell
Avg holding period · 11 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Turtle

Turtle aligns incentives between protocols and liquidity providers to surface unique yield opportunities. Its non-custodial system integrates with APIs and audited smart contracts to track liquidity flows and distribute rewards transparently. Turtle also offers advisory services for protocols seeking efficient liquidity incentives.

Read more on TURTLE